56% of DSM-IV Panel Members Had Pharma Financial Ties
The Fact
A 2006 study examined 170 members who contributed to DSM-IV and DSM-IV-TR diagnostic criteria. Ninety-five members — 56% — had one or more financial associations with pharmaceutical companies.
What This Means
Financial relationships between drug manufacturers and people involved in psychiatric diagnostic criteria were common in the population studied.
The most common categories were research funding (42% of all panel members), consulting (22%), and speakers bureaus (16%).
Sources
Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L. (2006). Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy and Psychosomatics, 75(3), 154–160. DOI: 10.1159/000091772.
Related Facts
- Did the Experts Who Wrote Psychiatric Diagnoses Have Drug-Company Ties? Some Panels, 100%.
- Do Medical Guideline Writers Have Drug-Company Ties? 87% in One Study.
- Were Women Kept Out of Drug Trials? For 16 Years, Many Were.
- Is There a Lab Test Behind Psychiatric Diagnoses? No — They Come From Committees.
